Isatuximab in combination as induction therapy for untreated multiple myeloma when an autologous stem cell transplant is suitable [TSID11949]

  • Awaiting development
  • GID-TA11465
  • Expected publication date: TBC

Status:
Awaiting development
Technology type:
Medicine
Decision:
Awaiting decision
Process:
STA Standard
ID number:
11949

Project Team

Project lead
Abbie Stephens

Email enquiries

If you have any queries please email [email protected]

Timeline

Key events during the development of the guidance:

Date Update
24 November 2023 Awaiting development. Status change linked to Topic Selection Decision being set to Selected
24 November 2023 Topic selection

For further information on our processes and methods, please see our CHTE processes and methods manual